CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Bristol-Myers Squibb Company v. Breckenridge Pharmaceutical, Inc.

1:17-cv-00375

Overview

Case Number 1:17-cv-00375
Filing Date 2017-04-05
Status Terminated
Termination Date 2017-10-25
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Breckenridge Pharmaceutical, Inc. Operating Company

Represented By

6 Attorneys Listed

John C. Phillips , Jr.

Phillips, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St

Scott Cunning

Email: scott.cunning@haynesboone.com

Elizabeth M. Crompton

Email: elizabethcrompton@parkerpoe.com

C. Kyle Musgrove

Email: kylemusgrove@parkerpoe.com

Huong Hguyen

Email: huong.nguyen@haynesboone.com

David A. Bilson

Phillips, Goldman, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200
Fax: +1 (302) 655-4210

Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street

Plaintiff

Pfizer Inc. Operating Company

Represented By

3 Attorneys Listed

Michael J. Farnan

Farnan LLP

Tel: +1 (302) 777-0338
Fax: +1 (302) 421-5870

919 North Market Street, 12th Floor

Brian E. Farnan

Farnan LLP

Tel: +1 (302) 777-0300
Fax: +1 (302) 777-0301

919 North Market Street, 12th Floor

Joseph J. Farnan , Jr.

Farnan LLP

Tel: +1 (302) 777-0300

919 North Market Street, 12th Floor

Bristol-Myers Squibb Company NPE (Individual / Inventor)

Represented By

10 Attorneys Listed

Tracey C. Allen

UNDELIVERABLE EMAIL 6/16/2021

Timothy A. Cook

Email: tim.cook@wilmerhale.com

Michael J. Farnan

Farnan LLP

Tel: +1 (302) 777-0338
Fax: +1 (302) 421-5870

919 North Market Street, 12th Floor

Kevin M. Yurkerwich

Email: kevin.yurkerwich@wilmerhale.com

Jeffrey T. Hantson

Email: jeffrey.hantson@wilmerhale.com

Heather M. Petruzzi

Email: heather.petruzzi@wilmerhale.com

Brian E. Farnan

Farnan LLP

Tel: +1 (302) 777-0300
Fax: +1 (302) 777-0301

919 North Market Street, 12th Floor

Andrew J. Danford

Email: andrew.danford@wilmerhale.com

Amy K. Wigmore

Email: amy.wigmore@wilmerhale.com

Joseph J. Farnan , Jr.

Farnan LLP

Tel: +1 (302) 777-0300

919 North Market Street, 12th Floor

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 4 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials 1 proceeding
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (4): 🇺🇸 US 🌐 PCT
Parallel Proceedings Across Jurisdictions (1 found):
PTAB: 1
USPTO PTAB Trial 2018-04-05
IPR2018-00892

Mylan Pharmaceuticals Inc. v. Pfizer Inc.

Asserted Patent
Status: Terminated-Settled
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US9326945
Apixaban formulations
Filed: 2011-02-24
Issued: 2016-05-03
Active (4.3 yrs remaining)
Expires: 2031-02-24

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Active Threat

Active Threat — Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).

Docket Entries

(43 total)
Pleading / Complaint

COMPLAINT for PATENT INFRINGEMENT filed against Breckenridge Pharmaceutical, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2116742.) - filed by Bristol-Myers Squibb Company, Pfizer Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(nmg) (Entered: 04/06/2017)

Entry #1 • 2017-04-05
1
Pleading / Complaint

COMPLAINT for PATENT INFRINGEMENT filed against Breckenridge Pharmaceutical, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2116742.) - filed by Bristol-Myers Squibb Company, Pfizer Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(nmg) (Entered: 04/06/2017)

Entry #1 • 2017-04-05
2
Pleading / Complaint

COMPLAINT for PATENT INFRINGEMENT filed against Breckenridge Pharmaceutical, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2116742.) - filed by Bristol-Myers Squibb Company, Pfizer Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(nmg) (Entered: 04/06/2017)

Entry #1 • 2017-04-05
2
Pleading / Complaint

COMPLAINT for PATENT INFRINGEMENT filed against Breckenridge Pharmaceutical, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2116742.) - filed by Bristol-Myers Squibb Company, Pfizer Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(nmg) (Entered: 04/06/2017)

Entry #1 • 2017-04-05
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) (Entered: 04/06/2017)

Entry #2 • 2017-04-05
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc